Drug Database
Back to search

Belgium· BE-AMP-SAM442705-00

Margotexeltis 0.02 mg - 3 mg

A drospirenone and ethinylestradiol product containing ethinylestradiol, registered in Belgium by Exeltis Germany. The same ATC class is registered in 13 of our 19 countries.

ATC G03AA12

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMargotexeltis 0.02 mg - 3 mgATCG03AA12REGISTER NO.BE-AMP-SAM442705-00PACKS LISTED4CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethinylestradiolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Drospirenone and ethinylestradiol is registered in 13 of 19 countries.

Countries holding a registration under ATC G03AA12 (drospirenone and ethinylestradiol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search drospirenone and ethinylestradiol products by name

Drospirenone and ethinylestradiol · ATC G03AA12

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ethinylestradiol
Manufacturer
Exeltis Germany
Country
Belgium (BE)
ATC code
G03AA12
ATC class
Drospirenone and ethinylestradiol
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 4

  • be_apb
    3105392
  • be_apb
    7709694
  • be_apb
    3105384
  • be_apb
    3105400

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

517 interactions on record for drospirenone and ethinylestradiol.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check drospirenone and ethinylestradiol against other medicinesHow interaction checks work

Drospirenone and ethinylestradiol · interactions on record

517 records

  • 50 severe
  • 386 moderate
  • 49 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • HeminB06AB01severe
  • BosentanC02KX01severe
  • GriseofulvinD01AA08severe

32 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Drospirenone and ethinylestradiol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All drospirenone and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Ethinyloestradiol Effik
  • Netherlands · Acelyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc47abdb-709a-4025-aa1c-68d6c2bbf9a1
GET /v1/drugs/fc47abdb-709a-4025-aa1c-68d6c2bbf9a1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Margotexeltis  0.02 mg - 3 mg",
  "name_fr": "Margotexeltis  0.02 mg - 3 mg",
  "name_nl": "Margotexeltis  0.02 mg - 3 mg",
  "amp_code": "SAM442705-00",
  "strengths": [
    "0.0200",
    "0.0200",
    "0.0200",
    "0.0200",
    "0.0200",
    "3.0000",
    "3.0000",
    "3.0000",
    "3.0000",
    "3.0000",
    "44.0000",
    "0.9000"
  ],
  "pack_count": 5,
  "substances": [
    "Ethinylestradiol",
    "Drospirenone",
    "Lactose Monohydrate",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Drospirenone and Ethinylestradiol",
  "authorisation_numbers": [
    "BE442705"
  ]
}
API referenceMCP serverPlans

See everything about drospirenone and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console